ABSTRACT

The treatment of coronary heart disease in patients with renal impairment is often complicated by the presence of multiple co-morbidities and limitations in drug prescription.

The present chapter evaluates the impact of baseline renal function on the 1-year mortality and repeat intervention of patients treated with either conventional bare stents or sirolimus-eluting stents (SES).